Brief report: Short stature caused by a mutant growth hormone

New England Journal of Medicine

Volumn 334, Issue 7, 1996, Pages 432-436

  Takahashi, Yutaka ^a   Kaji, Hidesuke ^a   Okimura, Yasuhiko ^a   Goji, Katsumi ^b   Abe, Hiromi ^a   Chihara, Kazuo ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KOBE CHILDREN S HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; GROWTH HORMONE RECEPTOR; RECEPTOR RESERVE; RECOMBINANT GROWTH HORMONE;

ADULT; ARTICLE; BINDING AFFINITY; CASE REPORT; CHILD; FEMALE; GENE MUTATION; GROWTH HORMONE DEFICIENCY; HORMONE DETERMINATION; HUMAN; HUMAN CELL; ISOELECTRIC FOCUSING; MALE; PRIORITY JOURNAL; SHORT STATURE;

AMINO ACID SEQUENCE; BASE SEQUENCE; CHILD, PRESCHOOL; DNA, COMPLEMENTARY; GENE AMPLIFICATION; GROWTH DISORDERS; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MOLECULAR SEQUENCE DATA; PEDIGREE; POINT MUTATION;

EID: 0030019680     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199602153340704     Document Type: Article

References (27)

1. Kowarski AA, Schneider J, Ben-Galim E, Weldon VV, Daughaday WH Growth failure with normal serum RIA-GH and low somatomedin activity, somatomedin restoration and growth acceleration after exogenous GH J Clin Endocrinol Metab 1978;47:461-4.
2. Valenta LJ, Sigel MB, Lesmak MA, et al Pituitary dwarfism in a patient with circulating abnormal growth hormone polymers. N Engl J Med 1985; 312.214-7.
3. Hayek A, Peake GT, Greenberg RE. A new syndrome of short stature due to biologically inactive but immunoreactive growth hormone. Pediatr Res 1978;12:413 abstract.
4. Rudman D, Kutner MH, Blackston RD, Cushman RA, Bain RP, Patterson JH. Children with normal-van ant short stature treatment with human growth hormone for six months. N Engl J Med 1981;305:123-31.
5. Frazer TE, Gavin JR, Daughaday WH, Hillman RE, Weldon VV. Growth hormone - dependent growth failure. J Pediatr 1982;101:12-5.
6. Plotnick LP, Van Meter QL, Kowarski AA Human growth hormone treatment of children with growth failure and normal growth hormone levels by immunoassay: lack of correlation with somatomedin generation. Pediatrics 1983,71:324-7.
7. Bright GM, Rogol AD, Johanson AJ, Blizzard RM. Short stature associated with normal growth hormone and decreased somatomedin-C concentrations: response to exogenous growth hormone. Pediatrics 1983,71:576-80.
8. Tanaka T, Shiu RPC, Gout PW, Beer CT, Noble RL, Friesen HG. A new sensitive and specific bioassay for lactogenic hormones, measurement of prolactin and growth hormone in human serum. J Clin Endocrinol Metab 1980;51:1058-63.
9. Okimura Y, Chihara K, Kita T, et al. Discordance between growth hormone (GH) responses after GH-releasing hormone and insulin hypoglycemia in myotonic dystrophy. J Clin Endocrinol Metab 1988;67:1074-9
10. Baxter RC, Martin JL. Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma. J Clin Invest 1986;78:1504-12.
11. Carlsson LMS, Rosberg S, Vitangcol RV, Wong WLT, Albertsson-Wikland K Analysis of 24-hour plasma profiles of growth hormone (GH)-binding protein, GH/GH-binding protein-complex, and GH in healthy children, J Clin Endocrinol Metab 1993;77.356-61.
12. Tsvetnitsky V, Auchi L, Nicolaou A, Gibbons WA. Characterization of phospholipid methylation in rat brain myelin. Biochem J 1995;307:239-44.
13. Gross-Bellard M, Oudet P, Chambon P. Isolation of high-molecular-weight DNA from mammalian cells Eur J Biochem 1973,36 32-8.
14. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning, a laboratory manual. Cold Spring Harbor, N.Y., Cold Spring Harbor Laboratory Press, 1982.
15. de Martynoff G, Pays E, Vassart G. Synthesis of a full length DNA complementary to thyroglobulin 33 S messenger RNA. Biochem Biophys Res Commun 1980;93:645-53.
16. 125I-human growth hormone to specific receptors in human cultured lymphocytes characterization of the interaction and a sensitive radioreceptor assay J Biol Chem 1974;249:1661-7.
17. Silva CM, Weber MJ, Thorner MO. Stimulation of tyrosine phosphorylation in human cells by activation of the growth hormone receptor. Endocrinology 1993;132:101-8
18. Rosenbloom AL. The chronicle of growth hormone receptor deficiency (Laron syndrome). Acta Paediatr Suppl 1992;383.117-20.
19. Cunningham BC, Ultsch M, De Vos AM, Mulkerrin MG, Clauser KR, Wells JA. Dimerization of extracellular domain of the human growth hormone receptor by a single hormone molecule. Science 1991,254:821-5.
20. Fuh G, Cunningham BC, Fukunaga R, Nagata S, Goeddel DV, Wells JA. Rational design of potent antagonists to the human growth hormone receptor Science 1992;256:1677-80.
21. Silva CM, Day RN, Weber MJ, Thorner MO. Human growth hormone (GH) receptor is characterized as the 134-kilodalton tyrosine-phosphorylated protein activated by GH treatment in IM-9 cells Endocrinology 1993;133 2307-12.
22. Argetsinger LS, Campbell GS, Yang X, et al. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase Cell 1993;74:237-44
23. Silva CM, Lu H, Weber MJ. Thorner MO Differential tyrosine phosphorylation of JAK1, JAK2, and STAT1 fay growth hormone and interferon-γ in IM-9 cells. J Biol Chem 1994;269:27532-9.
24. Gronowski AM, Zhong Z, Wen Z, Thomas MJ, Darnell JE Jr, Rotwein P In vivo growth hormone treatment rapidly stimulates the tyrosine phosphorylation and activation of Stat3 Mol Endocrinol 1995,9:171-7.
25. Herington AC, Ymer SI, Tiong TS. Does the serum binding protein for growth hormone have a functional role? Acta Endocrinol (Copenh) 1991, 124:Suppl 2:14-20.
26. Baumann G, Amburn KD, Buchanan TA The effect of circulating growth hormone-binding protein on metabolic clearance, distribution, and degradation of human growth hormone J Clin Endocrinol Metab 1987;64:657-60.
27. Baumann G, Shaw MA, Buchanan TA, In vivo kinetics of a covalent growth hormone-binding protein complex. Metabolism 1989,38 330-3.